MedTrace Logo

Laughter Yoga- Integrated Virtual Reality Nature Exploration in Early Stage of Chemotherapy

NCT07798661 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-09-01

No results posted yet for this study

Summary

After obtaining informed consent, pre-test applications will be performed on participants in the experimental and control groups following randomization, and information regarding treatment plans will be recorded. Patients in the experimental group will receive laughter yoga practice integrated with virtual reality videos during chemotherapy infusion. The practice is planned to be once a week for four weeks. High-resolution, adjustable virtual reality glasses with head and hand tracking features will be used for the virtual reality application. The videos will consist of relaxing content such as nature walks, beach and sea views, and will be prepared in three-dimensional, 360-degree viewing angles integrated with laughter yoga exercises. Personalized video content will be created according to the participants' preferences, and the viewing time will be limited to 10 minutes for each application. After the completion of the fourth course, data collection tools will be re-administered for post-testing purposes.

Conditions

  • Patiens in Early Stage of Chemotherapy

Interventions

BEHAVIORAL

laughter yoga-integrated virtual reality

A digital-based behavioral approach for symptom control

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-15
Primary Completion
2027-01-30
Completion
2027-03-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07798661 on ClinicalTrials.gov